Company: IMNN
Filing Date: 2025-05-19
Form Type: S-1/A
Source: 0001641172-25-011388
Chunk: 66

Company: Imunon, Inc.
Filing Date: 2025-05-19
Form: S-1/A
Chunk 66
---
 situated stockholders of Imunon, Inc. and defendants, incorporated herein by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company, filed on June 16, 2020 (SEC File No. 001-15911). |
| 10.26   |     | Form of Exercise Agreement, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on March 13, 2020 (SEC File No. 001-15911).                                                                                                                                                                                                                                                                                                                              |
| 10.27   |     | At the Market Offering Agreement, dated May 25, 2022 by and between Celsion Corporation and H.C. Wainwright & Co. LLC, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on May 25, 2022, (SEC File NO. 001-15911).                                                                                                                                                                                                                                    |
| 10.28   |     | Amendment No. 1, dated May 15, 2024, to At the Market Offering Agreement, by and between Imunon, Inc. and H.C. Wainwright & Co. LLC, incorporated by reference to Exhibit 1.3 to the Company’s Registration Statement on Form S-3 (No. 333-279425) filed on May 15, 2024.                                                                                                                                                                                                                              |
| 10.29   |     | Form of Securities Purchase Agreement, dated as of July 30, 2024, by and among the Company and each purchaser party thereto, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on July 31, 2024 (SEC File No. 001-15911).                                                                                                                                                                                                                              |
| 10.30+  |     | Form of Securities Purchase Agreement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

| II-5 |

| 10.31# 
 21.1   |     | Form of Exchange Agreement, dated May 12, 2025.                                                                                                                                         
 Subsidiaries of Imunon, Inc., incorporated by reference to Exhibit 21.1 to the Annual Report on Form 10-K of the Company for the year ended December 31, 2024 (SEC File No. 001-15911). |
|:-------|:----|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|